Aperio Group LLC bought a new stake in shares of Teladoc Inc (NYSE:TDOC) during the 2nd quarter, Holdings Channel reports. The institutional investor bought 3,462 shares of the health services provider’s stock, valued at approximately $201,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. We Are One Seven LLC grew its position in Teladoc by 241.1% in the 1st quarter. We Are One Seven LLC now owns 2,845 shares of the health services provider’s stock valued at $115,000 after acquiring an additional 2,011 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Teladoc by 68.8% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,874 shares of the health services provider’s stock valued at $116,000 after acquiring an additional 1,171 shares during the last quarter. Garner Asset Management Corp bought a new position in Teladoc in the 2nd quarter valued at $200,000. Pier 88 Investment Partners LLC bought a new position in Teladoc in the 2nd quarter valued at $201,000. Finally, Rockefeller Capital Management L.P. bought a new position in Teladoc in the 1st quarter valued at $154,000.
In other Teladoc news, insider Lewis Levy sold 1,285 shares of the company’s stock in a transaction on Wednesday, August 15th. The stock was sold at an average price of $70.80, for a total value of $90,978.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jason N. Gorevic sold 25,000 shares of the company’s stock in a transaction on Friday, June 15th. The stock was sold at an average price of $60.21, for a total value of $1,505,250.00. Following the completion of the sale, the chief executive officer now owns 611,184 shares of the company’s stock, valued at $36,799,388.64. The disclosure for this sale can be found here. Insiders sold a total of 261,947 shares of company stock valued at $17,182,451 over the last quarter. Company insiders own 3.95% of the company’s stock.
Several equities analysts have commented on TDOC shares. Berenberg Bank started coverage on Teladoc in a research report on Monday, July 9th. They issued a “buy” rating and a $72.00 price objective on the stock. Jefferies Financial Group set a $74.00 price objective on Teladoc and gave the company a “buy” rating in a research report on Wednesday, July 11th. Wells Fargo & Co reaffirmed a “buy” rating and issued a $70.00 price objective on shares of Teladoc in a research report on Thursday, August 2nd. Cantor Fitzgerald reaffirmed a “hold” rating and issued a $52.00 price objective on shares of Teladoc in a research report on Wednesday, August 1st. Finally, Robert W. Baird upped their price objective on Teladoc from $42.00 to $50.00 and gave the company a “neutral” rating in a research report on Tuesday, June 5th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $65.10.
Shares of TDOC stock opened at $76.45 on Friday. Teladoc Inc has a twelve month low of $27.30 and a twelve month high of $79.64. The firm has a market capitalization of $5.39 billion, a price-to-earnings ratio of -46.52 and a beta of 0.58. The company has a debt-to-equity ratio of 0.58, a current ratio of 3.14 and a quick ratio of 3.14.
Teladoc (NYSE:TDOC) last issued its earnings results on Wednesday, August 1st. The health services provider reported ($0.37) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.38) by $0.01. Teladoc had a negative return on equity of 19.10% and a negative net margin of 37.78%. The business had revenue of $94.60 million during the quarter, compared to analysts’ expectations of $91.56 million. During the same period in the prior year, the business earned ($0.28) EPS. The business’s revenue for the quarter was up 112.1% compared to the same quarter last year. equities analysts forecast that Teladoc Inc will post -1.51 EPS for the current year.
Teladoc, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Featured Story: Calculate Your Return on Investment (ROI)
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Inc (NYSE:TDOC).
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.